PMGC Holdings Sees Stock Jump on NorthStrive's Space Health Patent Push

PMGC Holdings (ELAB) stock surged 4.43% to $6.37 after its subsidiary NorthStrive expanded its patent strategy into space health.

NorthStrive filed two U.S. patent applications covering EL-22 and EL-32 for preserving lean muscle mass during prolonged microgravity exposure.

The filings extend NorthStrive's existing work beyond obesity-related muscle loss into human spaceflight applications, targeting biological pathways that regulate skeletal muscle growth and maintenance.